Literature DB >> 17017522

Nongenetic causes of Parkinson's disease.

A R Chade1, M Kasten, C M Tanner.   

Abstract

Study of the nongenetic causes of Parkinson's disease (PD) was encouraged by discovery of a cluster of parkinsonism produced by neurotoxic pyridine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the 1980s. Since that time, epidemiologic investigations have suggested risk factors, though their results do not establish causality. Pesticide exposure has been associated with increased risk in many studies. Other proposed risks include rural residence and certain occupations. Cigarette smoking, use of coffee/caffeine, and non-steroidal antiinflammatory drugs (NSAIDs) all appear to lower risk of PD, while dietary lipid and milk consumption, high caloric intake, and head trauma may increase risk. The cause of PD is likely multifactorial. Underlying genetic susceptibility and combinations of risk and protective factors likely all contribute. The combined research effort by epidemiologists, geneticists, and basic scientists will be needed to clarify the cause(s) of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017522     DOI: 10.1007/978-3-211-45295-0_23

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  21 in total

1.  PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Authors:  Bin Zheng; Zhixiang Liao; Joseph J Locascio; Kristen A Lesniak; Sarah S Roderick; Marla L Watt; Aron C Eklund; Yanli Zhang-James; Peter D Kim; Michael A Hauser; Edna Grünblatt; Linda B Moran; Silvia A Mandel; Peter Riederer; Renee M Miller; Howard J Federoff; Ullrich Wüllner; Spyridon Papapetropoulos; Moussa B Youdim; Ippolita Cantuti-Castelvetri; Anne B Young; Jeffery M Vance; Richard L Davis; John C Hedreen; Charles H Adler; Thomas G Beach; Manuel B Graeber; Frank A Middleton; Jean-Christophe Rochet; Clemens R Scherzer
Journal:  Sci Transl Med       Date:  2010-10-06       Impact factor: 17.956

Review 2.  Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.

Authors:  Dawn Béraud; Kathleen A Maguire-Zeiss
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

3.  β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease.

Authors:  Jason R Richardson; Ananya Roy; Stuart L Shalat; Brian Buckley; Bozena Winnik; Marla Gearing; Allan I Levey; Stewart A Factor; Padraig O'Suilleabhain; Dwight C German
Journal:  Neurotoxicology       Date:  2011-05-17       Impact factor: 4.294

4.  Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.

Authors:  Anil Kachroo; Michael C Irizarry; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2010-02-24       Impact factor: 5.330

5.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

6.  Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.

Authors:  Reno C Reyes; Giordano Fabricio Cittolin-Santos; Ji-Eun Kim; Seok Joon Won; Angela M Brennan-Minnella; Maya Katz; Graham A Glass; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

7.  Parkinsonism in patients with a history of amphetamine exposure.

Authors:  Chadwick W Christine; Elisabeth R Garwood; Lauren E Schrock; Daniel E Austin; Charles E McCulloch
Journal:  Mov Disord       Date:  2010-01-30       Impact factor: 10.338

8.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

9.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01

10.  Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease.

Authors:  Hongyu Diao; Xinxing Li; Sheng Hu; Yunhui Liu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.